Traws Pharma Secures $50 Million Commitment from Roth Principal Investments
PUBLIC · TRAWOct 23, 2026
Amount Raised
$50 Million
Round Type
Post-IPO Equity
NewtownBiotechnology
Investors
Roth Principal Investments, LLC
Description
On October 23, 2026, Traws Pharma, Inc. entered into a Common Stock Purchase Agreement with Roth Principal Investments, granting them the right to purchase up to $50 million in newly issued shares of the company's common stock. This agreement allows Traws Pharma to raise funds based on its discretion over a specified period. The timing and amount of sales will be determined by Traws Pharma under the terms of the agreement.
Who to call at Traws Pharma, and when
A new round usually means Traws Pharma is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Traws Pharma raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Traws Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Traws Pharma. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Traws Pharma
Location
12 Penns Trail
Newtown, Pennsylvania, United States
About
Traws Pharma’s novel, proprietary, targeted multi-kinase CDK4/6 inhibitor narazaciclib is being evaluated in dose ranging Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole, with the aim to define the recommended phase 2 dose for further development in endometrial cancer. Pre-clinically narazaciclib has shown efficacy in breast cancer cells resistant to palbociclib, assumed due to targeting proteins such as CSF-1 and FGFR implicated in resistance to these agents. Targeting ARK-5 (also known as NUAC 1) suggests additional tumors can be studied when high expression of these proteins are correlated with resistance.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Traws Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
NewtownBiotechnology